As of Oct 21
| -0.02 / -0.84%|
The 1 analysts offering 12-month price forecasts for Accretive Health Inc have a median target of 3.50, with a high estimate of 3.50 and a low estimate of 3.50. The median estimate represents a +47.68% increase from the last price of 2.37.
The current consensus among 1 polled investment analysts is to Buy stock in Accretive Health Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.